Scholarlink

<p>Marine macroalgae such as <i>Sargassum thunbergii</i> (ST) represent an abundant but underutilized biomass resource with strong potential for valorization into high-value bioactive compounds. In this study, a scalable and sustainable extraction process was developed to obtain fucoidan from <i>S. thunbergii</i>. The process involved 1% acetic acid soaking, hot water extraction, 5% CaCl₂ treatment at pH 11, ethanol precipitation (1:3 v/v) at pH 5, and freeze drying. The resulting fucoidan (STF) exhibited a high sulfate (~ 16%) and fucose (~ 19–20%) content, while retaining essential minerals and meeting safety standards (total arsenic: 3.0&#xa0;mg/kg; inorganic arsenic: 0.79&#xa0;mg/kg). In vitro analyses demonstrated that STF enhances nitric oxide production, activates the NF-κB signaling pathway, and suppresses Th17 cell polarization, indicating strong immunomodulatory potential. At in vivo, STF and chitooligosaccharides (COS) were evaluated using a DSS-induced zebrafish intestinal inflammation model. Both STF and COS treatment significantly decreased pro-inflammatory IL-1β protein levels, potentially contributing in gut microbiota balance, characterized by increased microbial diversity, enrichment of beneficial taxa such as <i>Lactobacillus,</i> and reduced dominance of <i>Cetobacterium</i>. These findings highlight the feasibility of valorizing <i>S. thunbergii</i> biomass into bioactive fucoidan with potential applications in functional foods, dietary supplements, and nutraceuticals promoting intestinal and immune health.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Scalable Valorization of Sargassum thunbergii Biomass to Produce Bioactive Compounds with Immunomodulatory for Gut Health Applications

  • 期刊论文

  • 发表日期：

    2026年1月22日

查看全文
  • D. S. Dissanayake,
  • N. M. Liyanage,
  • M. J. M. S. Kurera,
  • H. H. A. C. K. Jayawardhana,
  • Fengqi Yang,
  • Dandan Xiao,
  • Jun-Geon Je,
  • Chan-Young Kim,
  • Jae Yong Song,
  • Youngjun Park,
  • Eun-Jung Kim,
  • You-Jin Jeon,
  • Kyung Yuk Ko

摘要

Marine macroalgae such as Sargassum thunbergii (ST) represent an abundant but underutilized biomass resource with strong potential for valorization into high-value bioactive compounds. In this study, a scalable and sustainable extraction process was developed to obtain fucoidan from S. thunbergii. The process involved 1% acetic acid soaking, hot water extraction, 5% CaCl₂ treatment at pH 11, ethanol precipitation (1:3 v/v) at pH 5, and freeze drying. The resulting fucoidan (STF) exhibited a high sulfate (~ 16%) and fucose (~ 19–20%) content, while retaining essential minerals and meeting safety standards (total arsenic: 3.0 mg/kg; inorganic arsenic: 0.79 mg/kg). In vitro analyses demonstrated that STF enhances nitric oxide production, activates the NF-κB signaling pathway, and suppresses Th17 cell polarization, indicating strong immunomodulatory potential. At in vivo, STF and chitooligosaccharides (COS) were evaluated using a DSS-induced zebrafish intestinal inflammation model. Both STF and COS treatment significantly decreased pro-inflammatory IL-1β protein levels, potentially contributing in gut microbiota balance, characterized by increased microbial diversity, enrichment of beneficial taxa such as Lactobacillus, and reduced dominance of Cetobacterium. These findings highlight the feasibility of valorizing S. thunbergii biomass into bioactive fucoidan with potential applications in functional foods, dietary supplements, and nutraceuticals promoting intestinal and immune health.

Graphical Abstract